Sarissa Capital Master Fund II LP 3
3 · Iterum Therapeutics plc · Filed Nov 23, 2020
Insider Transaction Report
Form 3
Denner Alexander J
10% Owner
Holdings
- (indirect: See footnotes)
6.500% Exchangeable Senior Subordinated Note due 2025
Exercise: $0.78From: 2021-01-21Exp: 2025-01-31→ Ordinary Shares (19,292,768 underlying)
Footnotes (4)
- [F1]See Exhibit 99.1
- [F2]See Exhibit 99.1
- [F3]See Exhibit 99.1
- [F4]See Exhibit 99.1